Variant report
Variant | esv3431891 |
---|---|
Chromosome Location | chr2:125183752-125186914 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:125185428..125187787-chr2:125189293..125191485,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535037099 | chr2:125183808-125183809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145607012 | chr2:125183820-125183821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193083731 | chr2:125183822-125183823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537323131 | chr2:125183828-125183829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557634452 | chr2:125183932-125183933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574278491 | chr2:125184024-125184025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536804825 | chr2:125184058-125184059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555506671 | chr2:125184080-125184081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11890422 | chr2:125184125-125184126 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs77860887 | chr2:125184138-125184139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563901994 | chr2:125184154-125184155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577913727 | chr2:125184155-125184156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541809447 | chr2:125184184-125184185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114382446 | chr2:125184186-125184187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112931256 | chr2:125184193-125184194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567680477 | chr2:125184197-125184198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559811297 | chr2:125184228-125184229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528563520 | chr2:125184322-125184323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577628117 | chr2:125184331-125184332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551782646 | chr2:125184338-125184339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571548431 | chr2:125184362-125184363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377151517 | chr2:125184405-125184406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185667954 | chr2:125184407-125184408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567914520 | chr2:125184421-125184422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201846354 | chr2:125184457-125184458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536860355 | chr2:125184465-125184466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190626412 | chr2:125184488-125184489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544612495 | chr2:125184529-125184530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565794283 | chr2:125184538-125184539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2042657 | chr2:125184570-125184571 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs181041148 | chr2:125184602-125184603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577574699 | chr2:125184632-125184633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117254173 | chr2:125184653-125184654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183489667 | chr2:125184746-125184747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573563254 | chr2:125184756-125184757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542448991 | chr2:125184789-125184790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Developmental delay | 21147756 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:125183800-125184600 | Enhancers | Liver | Liver |
2 | chr2:125183800-125184800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr2:125183800-125184800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr2:125183800-125184800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr2:125184000-125184600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr2:125184000-125184600 | Enhancers | Aorta | Aorta |
7 | chr2:125184000-125184800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr2:125184000-125184800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr2:125184200-125184600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr2:125184200-125184600 | Enhancers | Left Ventricle | heart |
11 | chr2:125184200-125184600 | Enhancers | Right Atrium | heart |
12 | chr2:125184200-125184800 | Enhancers | H1 Cell Line | embryonic stem cell |